The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study

X Xinyang Li Y Yingying Liu (Institute of Intelligent Machines, Hefei Institutes of Physical Science) X Xueyan Zhu H Hua Jin X Xiaoxuan Zhang L Lei Wang Y Yingchun Cui F Feng Xu (Faculty of Pharmaceutical Sciences) Y Yangwei Wang Y Yanyan Song W Wenpeng Cui

Article Details

Volume / Issue Vol. 15, Issue 1
Published July 01, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (11)

X

Xinyang Li

Y

Yingying Liu

Institute of Intelligent Machines, Hefei Institutes of Physical Science

X

Xueyan Zhu

H

Hua Jin

X

Xiaoxuan Zhang

L

Lei Wang

Y

Yingchun Cui

F

Feng Xu

Faculty of Pharmaceutical Sciences

Y

Yangwei Wang

Y

Yanyan Song

W

Wenpeng Cui